Prognostic Importance of the White Blood Cell Count for Coronary, Cancer, and All-Cause Mortality

Multiple Risk Factor Intervention Trial Research Group

Research output: Contribution to journalArticlepeer-review

326 Scopus citations


The relationship of white blood cell count (WBC) to fatal and nonfatal coronary heart disease (CHD) incidence and all-cause and cancer mortality was assessed in a subset of participants in the Multiple Risk Factor Intervention Trial (MRFIT). For this group of 6,222 middle aged men, total WBC count was found to be strongly and significantly related to risk of CHD, independent of smoking status. Change in WBC count from baseline to the annual examination just prior to the CHD event was found to be a significant and independent predictor of CHD risk. For each decrease in WBC count of 1,000/cu mm the risk for CHD death decreased 14%, controlling for baseline WBC count and other CHD risk factors (smoking, cholesterol level, diastolic blood pressure). The WBC count was strongly related cross-sectionally to cigarette smoking and smoking status as indicated by serum thiocyanate concentration. Smokers on average had a WBC count of 7,750/cu mm compared with 6,080/cu mm for nonsmokers. The WBC count was also significantly associated with cancer death, independent of reported smoking and serum thiocyanate levels.

Original languageEnglish (US)
Pages (from-to)1932-1937
Number of pages6
JournalJAMA: The Journal of the American Medical Association
Issue number14
StatePublished - Oct 11 1985
Externally publishedYes


Dive into the research topics of 'Prognostic Importance of the White Blood Cell Count for Coronary, Cancer, and All-Cause Mortality'. Together they form a unique fingerprint.

Cite this